FDA Approves New Non-Opioid Painkiller, Journavx: 'No Addiction Potential'
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...
Beachwood Planning Commission recommends zoning change for Commerce Park site where three apartment buildings are planned
Beachwood's Planning Commission recommended to City Council a zoning change for property at 23250 Commerce Park Drive, where ...
Earnings call transcript: iCAD Q3 2024 sees revenue rise, SaaS shift
CAD (NASDAQ:ICAD) (market cap: $85.26M), a leader in AI-powered breast cancer detection, reported its third-quarter 2024 financial results, demonstrating a 4% year-over-year increase in revenue to $4.